Laminin-associated integrins mediate Diffuse Intrinsic Pontine Glioma infiltration and therapy response within a...

Area of Science:

• Neuro-oncology
• Cancer Biology
• Stem Cell Biology

Background:

• Diffuse Intrinsic Pontine Glioma (DIPG) is a fatal pediatric brain cancer with poor treatment outcomes.
• Tumor cell adhesion to the extracellular matrix (ECM) is crucial for cancer cell invasion.
• The specific ECM proteins and integrin receptors involved in DIPG infiltration remain largely unidentified.

Purpose of the Study:

• To identify critical ECM proteins and integrin receptors mediating DIPG cell adhesion and migration.
• To develop and utilize a novel DIPG-neural assembloid model for studying DIPG infiltration.
• To investigate the therapeutic potential of targeting identified integrin receptors in DIPG.

Main Methods:

• Development of a DIPG-neural assembloid model comprising DIPG spheroids and human iPSC-derived neural organoids.
• Identification of laminin as a key ECM protein supporting DIPG cell adhesion and migration.
• Assessment of DIPG infiltration and response to treatment after knockdown of laminin-associated integrins within the assembloid model.

Main Results:

• Laminin was identified as a critical ECM component promoting DIPG cell adhesion and migration.
• Knockdown of laminin-associated integrins significantly inhibited DIPG cell infiltration in the assembloid model.
• Targeting laminin-associated integrins enhanced DIPG response to radiation and HDAC inhibitor treatments.

Conclusions:

• Laminin-associated integrins play a crucial role in DIPG progression and mediating treatment response.
• Disrupting these integrin receptors presents a potential therapeutic strategy for enhancing DIPG treatment.
• DIPG-neural assembloid models are valuable tools for DIPG research and drug discovery.